The Traderszone Network

Published in TZ Latest News 24 August, 2014 by The TZ Newswire Staff

Roche to purchase InterMune in $8.3 billion deal

Biotech firm Roche announced plans Sunday to buy InterMune for $8.3 billion on a fully diluted basis in an all-cash transaction.